
It is surprising to me that Biosensors price has drop. Last night, when this piece of new about cardiologists being concerned about drug eluting stent came out, the price of Conors went up by 6 %, while the price of current drud eluting stent manufacturers like Boston Sci, J &J dropped.
This is actually good news for new players like Conors and Biosensors, as ther technology uses a bio-degradable polymer, which is suppose to disappear in 6 mths, whereas current drug eluting stent companies use permanent polymers in their stent, and cardiologists are concerned that the blood clots formed (stent thrombosis), normally after a period of 6 mths - 2 years, are due to inflammation caused by these permanent polymers.
Yes, they found that these drug coated stents causes blood clots. Co, I am sure that the authorities conducting the certification of the CM mark will be more stringent in this aspect....which may lead to a delay in the in the CM mark for Biosensors.
Think this will be negative news for Biosensor's share price.
Some health-care stocks stumbled after The Wall Street Journal said several major hospitals were scaling back their use of expensive drug-coated coronary stents. As of now, Dow component Johnson & Johnson slid 70 cents to US$61.09, while Boston Scientific shed 59 cents to US$18.52.
Biosensors' price is going to fall.
doing very well today
Yes, That's right
Hi investor,
The US bio-device magazine you're referring to, is it the US Medical Device and Diagnostic Industry Magazine?
Yes, I bought some recently. I don't think that this piece of news will send the price going up, but it does help to built back a bit of the confidence factor that is currently lacking, in the company.
Hi Investor,
Are you invested in this stock? seems that with the top 50 ranking, Biosensors will soar quite high.
Are you invested in this stock? seems that with the top 50 ranking, Biosensors will soar quite high.
By coincidence - Biosensor has been rated as one of the top 50 bio-medical device company to watch in one of the US bio-device magazine, whereas one of their competitors, Connors Medsystem was not selected. This is quite surprising as Connors, whose own flagship product, which has just been approved, seems to be doing quite well, based on their last q106 conference call, although q206 would provide a better picture.
As an added caution - this is potentially a high risk stock - the company may not survive, if their flagship product does not do well, and they are in a very tough competitive environment, but a lucrative one - a 6 billion dollar mkt (US dollars).
Biosensor has fallen to this price because, in the results briefing - they indicate that the CE Mark approval for their flagship product (the biomatrix) may be delayed, when it was originally scheduled to be approved by h1 06.
According to the last conference call - they have submitted answers to the european authorities list of additional questions, somewhere in April, and the consensus is that it takes between 10-12 weeks to get confirmation of reply. This timeline will put the expected date to be somewhere in July, although it is by no means certain that it would indicate CE mark approval.
If the CE mark approval is announced - the stock will go much higher than the current price, and the converse is also true - more delays will mean that the price may drop further. Another reason for the recent drop were that investors were fearful that there might be something wrong with the product, thus jeapardising the approval process - however this has been viewed as unlikely, as some of their partners using their proprietary drug and polymer has reported excellent clinical outcomes (Partners Xtent and Devax).
If the CE mark is approved, and if the partners efforts in getting their own products for CE mark approval also succeeds (somewhere in 2007), then there is good potential for the company, with the proviso, that there are no litigations to hamper their growth. (they are in a very litigous industry, and they can get sued, whether rightly or wrongly)
Well is down alittle, hope those bot has clear their position, tmr maybe a better day as oil falling on electronic trading and Euro is green at this moment and DOW look good to nite.
Just when it price look attractive, up it goes, hope those bot liao some, hv some profit when they is, u never know what can happen tomorro.
Thanks Nostradamus,
Scary thing is that when prices are low, one is wary of getting in and when its going up, one is wary of bull trap.. guess its part and parcel of the trading scene..
Hi sandbox,
Bottom fishing means to buy (fish) a stock in the hope that the market has reached the bottom.
Biosensor never gone to new low, jus like that boss or big vested owner bot shares at the prices that is commited (see www.sgx.com.sg) and the prices is starting to look more attractive, esp prices going lower but never know how low is low and volume oso getting low and PE ratio is look more attrative (see ST paper on stocks) U can place your bid, go to the bottom where fish swim, (bottom fishing liao) please do your home work 1st and don buy on sentiments.
Hi teeth53,
me new to the trading scene.. Can I ask what is the meaning of bottom fishing?
Thanks...
Good time for bottom fishing oni, uncertainty is not over yet.
Hi All
Seems the CitiGroup is positive on this counter and has called for a buy ("Question of When, Not If") since price has gone down to below IPO's $0.70.
As i said again, now that almost all stocks is in red, so is Biosensor, is the same thing again, any thing that is up, take stock to clear, Biosen now to new low of $0.655 cents. most stocks will be going back to basic level that is worth their truth value and not their fair value. as an eg it's not easy for any companies to suddenly gain 10cents to a dollars in their profit suddenly, but maybe year after px appreciated in order to match it earning at that kind of value.
Big boys would hv oredi taken some profit liao. Ths biggest T* hv oredi taken their $$$ one/two mths ago, if px is seem been push up, profiting come in and oso to off load.